EP2943233B1 - Method for the filling of containers with autologous fresh blood components - Google Patents
Method for the filling of containers with autologous fresh blood components Download PDFInfo
- Publication number
- EP2943233B1 EP2943233B1 EP14706079.2A EP14706079A EP2943233B1 EP 2943233 B1 EP2943233 B1 EP 2943233B1 EP 14706079 A EP14706079 A EP 14706079A EP 2943233 B1 EP2943233 B1 EP 2943233B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- gap
- containers
- fact
- gaps
- communication
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims description 26
- 239000012503 blood component Substances 0.000 title claims description 24
- 238000004891 communication Methods 0.000 claims description 20
- 230000000694 effects Effects 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 description 5
- 238000011109 contamination Methods 0.000 description 2
- 210000004623 platelet-rich plasma Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 208000003322 Coinfection Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 150000005851 haem O derivatives Chemical class 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0209—Multiple bag systems for separating or storing blood components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2058—Connecting means having multiple connecting ports
- A61J1/2062—Connecting means having multiple connecting ports with directional valves
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/003—Filling medical containers such as ampoules, vials, syringes or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/02—Blood transfusion apparatus
- A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/04—Evacuating, pressurising or gasifying filled containers or wrappers by means of nozzles through which air or other gas, e.g. an inert gas, is withdrawn or supplied
Definitions
- the present invention relates to a method for the filling of containers with autologous fresh blood components such as, e.g., serum-eyedrops, platelet-rich plasma, etc....
- autologous fresh blood components have been generally introduced inside specific vessels, of the micro test tube type, having relative closing caps, from which an operator then takes the desired quantity and introduces it inside a plurality of containers intended for use on the patient.
- Another known method for the preparation of autologous blood component containers envisages filling a duct (dialysis infusate source) made of plastic material and closing such duct, e.g., by sealing in correspondence to a plurality of areas arranged in succession and spaced the one from the other, in such a way as to form a plurality of closed units.
- a duct dialysis infusate source
- This second method for the preparation of units containing platelet-rich plasma also has several drawbacks.
- the units of known type are not easy and safe to use and do not allow compliance with the hygienic-health requirements of applicable regulations as well as of haemoderivative certification bodies.
- WO 2011/095964 discloses a method for the filling of containers with autologous fresh blood components. Such method comprises the phases of providing an equipment defining a transit channel having at least a first gap associated with a syringe, a second gap associated with a bag containing fresh blood component and a third gap connected to a plurality of containers to be filled; insulating the second gap from the third gap and placing in communication the first gap with the third gap and insulating the first gap from the third gap and placing in communication the latter with the second gap.
- the main aim of the present invention is to provide a method for filling containers with autologous fresh blood components which is practical and safe to use.
- one object of the present invention is to provide a method for the filling of containers with autologous fresh blood components which allows complying with the hygienic-health requirements of applicable laws.
- Another object of the present invention is to prevent any risk of external contamination of the blood components during transfer into the containers to be filled (aliquotation in closed system).
- Yet another object of the present invention is, as far as possible, to separate the correct filling of the containers from the operator's skills and from the environment in which such filling is done.
- Another object of the present invention is to provide a method for the filling of containers with autologous fresh blood components that allows to overcome the mentioned drawbacks of the background art in the ambit of a simple, rational, easy, effective to use and low cost solution.
- the equipment 1 comprises at least a tubular element 2 which defines a transit channel 3.
- the channel 3 has at least a first gap 3a associated with an empty syringe 4 or the like, at least a second gap 3b associated with a bag 5 or the like containing an autologous fresh blood component and at least a third gap 3c connected to a plurality of containers 6 to be filled.
- the bag 5 may also be replaced by another syringe.
- the tubular element 2 has at least a main section 2a, from which extends at least a derivation 2b defining the second gap 3b.
- the equipment 1 comprises first valve means 7 arranged along the channel 3 and which can be operated to selectively place the openings 3a, 3b and 3c in communication with each other.
- the first valve means 7 can be moved between at least a first configuration of use, wherein the first gap 3a is in communication with the third gap 3c and the second gap 3b is insulated, a second configuration of use, wherein the second gap 3b is in communication with the third gap 3c and the first gap 3a is insulated, and a third configuration of use, wherein the first gap 3a is in communication with the second gap 3b and the third gap 3c is insulated.
- the first valve means 7 are, e.g., of the three-way tap type.
- the channel 3 also comprises a further gap 3d communicating with the outside. More in particular, the further gap 3d is placed between the first and the second gaps 3a and 3b.
- the equipment 1 comprises a filtering element 8 inserted inside the further gap 3d and suitable for preventing impurities from entering inside the channel 3.
- the equipment 1 also comprises second valve means 9 arranged along the channel 3 and which can be at least operated to put into communication/insulate the first gap 3a with/from the further gap 3d. More in particular, the second valve means 9 are movable between at least a first configuration of use, wherein the first gap 3a is in communication with the further gap 3d and is insulated from the other gaps 3b and 3c, and at least a second configuration of use, wherein the further gap 3d is insulated from the other gaps 3a, 3b and 3c.
- the second valve means 9 can also have further configurations of use suitable for insulating the further gap 3d from the first gap 3a and placing it in communication, depending on the configuration taken on by the first valve means 7, with at least one between the second and the third gaps 3b and 3c.
- the second valve means 9 are also, e.g., of the three-way tap type.
- the channel 3 has only a third gap 3c, with which is associated a supply duct 10 along which are arranged a plurality of containers 6 in series the one with the other.
- the tubular element 2 comprises a connecting element 11 which defines a plurality of third gaps 3c to which are connected the containers 6 to be filled.
- the method forming the subject of the present invention first of all provides for the insulation of the second gap 3b from the first and from the third gaps 3a and 3c and the placing in communication of the first gap 3a with the third gap 3c.
- This phase is performed by intervening on the first valve means 7 and, more in particular, moving the relative three-way tap to the first configuration of use.
- the second valve means 9 are operated so as to insulate the further gap 3d from the other gaps 3a, 3b and 3c.
- the air contained in the containers 6 is suctioned by means of the syringe 4 to create the vacuum inside the containers themselves.
- the first gap 3a must be insulated from the second and from the third gaps 3b and 3c and the first gap itself must be placed in communication with the further gap 3d.
- This phase is performed by moving the second valve means 9 to the first configuration of use. Subsequently, the air contained inside the syringe 4 is conveyed to the outside through the further gap 3d.
- the second valve means 9 are again moved to the second configuration of use, so as to insulate the first gap 3a from the further gap 3d, and the above phases are repeated until the containers 6 are completely emptied.
- the first gap 3a is then insulated from the third gap 3c and the second gap 3b is placed in communication with the third gap itself. This phase is performed by moving the first valve means 7 to the second configuration of use.
- the blood component contained in the bag 5 is suctioned by the containers 6 by effect of the vacuum created inside them.
- the substance contained in the bag 5 is introduced inside the channel 3 and enters inside the containers 6 passing through the third gap 3c.
- the containers 6 are then filled in succession following the introduction of the blood component contained in the bag 5 into the channel 3.
- the substance contained in the bag 5 is introduced inside the channel 3 and enters, substantially at the same time, inside the containers 6 passing through the respective third gaps 3c.
- the first and the second gaps 3a and 3b have to be insulated from the third gap 3c and the first and the second gaps 3a and 3b must be placed in communication with each other, after which the contents of the bag 5 are suctioned by means of the syringe 4.
- This operation is performed by moving the first valve means 7 to the third configuration of use.
- the second valve means 9 are arranged in the second configuration of use.
- the first valve means 7 are again moved to the first configuration of use and the contents suctioned by the syringe 4 are conveyed towards the containers 6.
- the phase of filling the syringe 4 with the contents of the bag 5 and the subsequent sending of such contents inside the containers 6 can be repeated until the containers themselves are completely full.
- the equipment according to the invention permits defining a closed and sterile path inside which the autologous fresh blood component is made to circulate and which, for this reason, permits preventing any type of external contamination.
- phases of the method forming the subject of the present invention permit very quickly and safely filling a plurality of containers and also make the success of such operations independent of the skills of the operator who performs them and of the environment in which the relative equipment is located.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Fluid Mechanics (AREA)
- Physics & Mathematics (AREA)
- Mechanical Engineering (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
- The present invention relates to a method for the filling of containers with autologous fresh blood components such as, e.g., serum-eyedrops, platelet-rich plasma, etc....
- Until now, autologous fresh blood components have been generally introduced inside specific vessels, of the micro test tube type, having relative closing caps, from which an operator then takes the desired quantity and introduces it inside a plurality of containers intended for use on the patient.
- Because these operations require the transfer of the blood components from one container to another, and therefore their transit into the external environment, they must obviously be performed in a sterile environment. Furthermore, the preparation of such containers must be done by trained medical or nursing personnel inasmuch as the therapeutic effectiveness of the preparation is strongly affected by the quality and ways in which the aforementioned phases are performed.
- It follows therefore that this known method of preparing containers with autologous fresh blood components besides being complicated to perform is also unsafe from a sanitary viewpoint and not therefore implementable on the basis of the applicable regulations on the subject. In fact, the correct performance of the operations described above is strictly correlated to the skills of the dedicated staff and to the environment where they are performed. These factors are highly restrictive inasmuch as they expose the preparation of the autologous blood component containers to various risks.
- Another known method for the preparation of autologous blood component containers envisages filling a duct (dialysis infusate source) made of plastic material and closing such duct, e.g., by sealing in correspondence to a plurality of areas arranged in succession and spaced the one from the other, in such a way as to form a plurality of closed units.
- These units are then opened, before being used, by cutting one of their respective extremities, e.g., using scissors, so as to make their contents available for use.
- This second method for the preparation of units containing platelet-rich plasma also has several drawbacks.
- More in particular, the units of known type are not easy and safe to use and do not allow compliance with the hygienic-health requirements of applicable regulations as well as of haemoderivative certification bodies.
- In fact, the opening of such units by means of scissors or the like, results in residues of organic material contained in the relative unit remaining on the scissors cutting area, with the consequent risk of contaminating the contents of the other units subsequently cut with the same scissors.
- This obviously involves the risk that the platelet contents of the units cut using already previously-used scissors will be polluted by the residues still on the scissors themselves, thereby negatively affecting their therapeutic properties and, above all, considerably increasing the risk of secondary infections in already immunodepressed patients and already debilitated organs.
-
WO 2011/095964 discloses a method for the filling of containers with autologous fresh blood components. Such method comprises the phases of providing an equipment defining a transit channel having at least a first gap associated with a syringe, a second gap associated with a bag containing fresh blood component and a third gap connected to a plurality of containers to be filled; insulating the second gap from the third gap and placing in communication the first gap with the third gap and insulating the first gap from the third gap and placing in communication the latter with the second gap. - The main aim of the present invention is to provide a method for filling containers with autologous fresh blood components which is practical and safe to use.
- Within such aim, one object of the present invention is to provide a method for the filling of containers with autologous fresh blood components which allows complying with the hygienic-health requirements of applicable laws.
- Another object of the present invention is to prevent any risk of external contamination of the blood components during transfer into the containers to be filled (aliquotation in closed system).
- Yet another object of the present invention is, as far as possible, to separate the correct filling of the containers from the operator's skills and from the environment in which such filling is done.
- Another object of the present invention is to provide a method for the filling of containers with autologous fresh blood components that allows to overcome the mentioned drawbacks of the background art in the ambit of a simple, rational, easy, effective to use and low cost solution.
- The objects mentioned above are achieved by the present method for the filling of containers with autologous fresh blood components, according to claim 1.
- Other characteristics and advantages of the present invention will become more evident from the description of a preferred, but not sole, embodiment of an equipment for the performance of the method according to the invention, illustrated purely as an example but not limited to the annexed drawings in which:
-
Figure 1 is a plan view from above of an equipment for the performance of the method according to the invention, in a first embodiment; -
Figure 2 is a plan view from above of an equipment for the performance of the method according to the invention, in a second embodiment. - With particular reference to such figures, globally indicated by 1 is an equipment for the filling of containers with autologous fresh blood components. The equipment 1 comprises at least a
tubular element 2 which defines atransit channel 3. - The
channel 3 has at least afirst gap 3a associated with anempty syringe 4 or the like, at least asecond gap 3b associated with abag 5 or the like containing an autologous fresh blood component and at least athird gap 3c connected to a plurality ofcontainers 6 to be filled. Thebag 5 may also be replaced by another syringe. - More in detail, in the embodiments shown in the illustrations, the
tubular element 2 has at least amain section 2a, from which extends at least aderivation 2b defining thesecond gap 3b. - Advantageously, the equipment 1 comprises first valve means 7 arranged along the
channel 3 and which can be operated to selectively place the 3a, 3b and 3c in communication with each other.openings - More in detail, the first valve means 7 can be moved between at least a first configuration of use, wherein the
first gap 3a is in communication with thethird gap 3c and thesecond gap 3b is insulated, a second configuration of use, wherein thesecond gap 3b is in communication with thethird gap 3c and thefirst gap 3a is insulated, and a third configuration of use, wherein thefirst gap 3a is in communication with thesecond gap 3b and thethird gap 3c is insulated. The first valve means 7 are, e.g., of the three-way tap type. - Preferably, the
channel 3 also comprises afurther gap 3d communicating with the outside. More in particular, thefurther gap 3d is placed between the first and the 3a and 3b.second gaps - Suitably, the equipment 1 comprises a filtering element 8 inserted inside the
further gap 3d and suitable for preventing impurities from entering inside thechannel 3. - As can be seen in the illustrations, the equipment 1 also comprises second valve means 9 arranged along the
channel 3 and which can be at least operated to put into communication/insulate thefirst gap 3a with/from thefurther gap 3d. More in particular, the second valve means 9 are movable between at least a first configuration of use, wherein thefirst gap 3a is in communication with thefurther gap 3d and is insulated from the 3b and 3c, and at least a second configuration of use, wherein theother gaps further gap 3d is insulated from the 3a, 3b and 3c. The second valve means 9 can also have further configurations of use suitable for insulating theother gaps further gap 3d from thefirst gap 3a and placing it in communication, depending on the configuration taken on by the first valve means 7, with at least one between the second and the 3b and 3c. The second valve means 9 are also, e.g., of the three-way tap type. In the first embodiment shown in thethird gaps figure 1 , thechannel 3 has only athird gap 3c, with which is associated asupply duct 10 along which are arranged a plurality ofcontainers 6 in series the one with the other. - In the second embodiment shown in
figure 2 , thetubular element 2 comprises a connectingelement 11 which defines a plurality ofthird gaps 3c to which are connected thecontainers 6 to be filled. - The operation of the equipment 1 in the performance of the method according to the invention is described below.
- Before proceeding to execute the phases required to fill the
containers 6, it is obviously best to connect theempty syringe 4 to thefirst gap 3a and thebag 5, containing the blood component to be introduced into the containers themselves, to thesecond gap 3b. - The method forming the subject of the present invention first of all provides for the insulation of the
second gap 3b from the first and from the 3a and 3c and the placing in communication of thethird gaps first gap 3a with thethird gap 3c. This phase is performed by intervening on the first valve means 7 and, more in particular, moving the relative three-way tap to the first configuration of use. Suitably, in this phase, the second valve means 9 are operated so as to insulate thefurther gap 3d from the 3a, 3b and 3c.other gaps - After proceeding this way, the air contained in the
containers 6 is suctioned by means of thesyringe 4 to create the vacuum inside the containers themselves. - In the event of air remaining inside the
containers 6, it is best to proceed with the following phases to complete the emptying of same. In particular, after removing the air by means of thesyringe 4, thefirst gap 3a must be insulated from the second and from the 3b and 3c and the first gap itself must be placed in communication with thethird gaps further gap 3d. This phase is performed by moving the second valve means 9 to the first configuration of use. Subsequently, the air contained inside thesyringe 4 is conveyed to the outside through thefurther gap 3d. - After emptying the
syringe 4 of the air contained inside it, the second valve means 9 are again moved to the second configuration of use, so as to insulate thefirst gap 3a from thefurther gap 3d, and the above phases are repeated until thecontainers 6 are completely emptied. - Once the air has been removed from the
containers 6, thefirst gap 3a is then insulated from thethird gap 3c and thesecond gap 3b is placed in communication with the third gap itself. This phase is performed by moving the first valve means 7 to the second configuration of use. - At this point, the blood component contained in the
bag 5 is suctioned by thecontainers 6 by effect of the vacuum created inside them. - More in detail, in the first embodiment, the substance contained in the
bag 5 is introduced inside thechannel 3 and enters inside thecontainers 6 passing through thethird gap 3c. Thecontainers 6 are then filled in succession following the introduction of the blood component contained in thebag 5 into thechannel 3. - In the second embodiment shown in
figure 2 , on the other end, the substance contained in thebag 5 is introduced inside thechannel 3 and enters, substantially at the same time, inside thecontainers 6 passing through the respectivethird gaps 3c. - In case of its being necessary to introduce a further quantity of the blood component contained in the
bag 5 inside thecontainers 6, the first and the 3a and 3b have to be insulated from thesecond gaps third gap 3c and the first and the 3a and 3b must be placed in communication with each other, after which the contents of thesecond gaps bag 5 are suctioned by means of thesyringe 4. This operation is performed by moving the first valve means 7 to the third configuration of use. During this phase, the second valve means 9 are arranged in the second configuration of use. - Subsequently, the first valve means 7 are again moved to the first configuration of use and the contents suctioned by the
syringe 4 are conveyed towards thecontainers 6. - The phase of filling the
syringe 4 with the contents of thebag 5 and the subsequent sending of such contents inside thecontainers 6 can be repeated until the containers themselves are completely full. - It has in practice been ascertained how the invention achieves the proposed objects and in particular, the fact is underlined that the method and the equipment forming the subject of the present invention permit easily and safely filling a plurality of containers with autologous fresh blood components.
- In particular, the equipment according to the invention permits defining a closed and sterile path inside which the autologous fresh blood component is made to circulate and which, for this reason, permits preventing any type of external contamination.
- Furthermore, the phases of the method forming the subject of the present invention permit very quickly and safely filling a plurality of containers and also make the success of such operations independent of the skills of the operator who performs them and of the environment in which the relative equipment is located.
Claims (8)
- Method for the filling of containers with autologous fresh blood components, comprising the following phases of :a) providing an equipment (1) defining a transit channel (3) having at least a first gap (3a), an empty syringe (4) associated with said first gap (3a), at least a second gap (3b) associated with a bag (5) or a another syringe containing an autologous fresh blood component and at least a third gap (3c) connected to a plurality of containers (6) to be filled;b) insulating said second gap (3b) from said third gap (3c) and placing in communication said first gap (3a) with said third gap (3c);characterized by the fact that it comprises the following phases of:c) suctioning the air contained in said containers (6) to be filled by means of said syringe (4) so as to define a vacuum inside them;d) insulating said first gap (3a) from said third gap (3c) and placing in communication the latter with said second gap (3b), said containers suctioning the contents of said bag (5) due to the effect of the vacuum defined inside them.
- Method according to claim 1, characterized by the fact that it comprises, after the phase d), the following phases of:e) insulating said first and second gaps (3a, 3b) from said third gap (3c) and placing them in communication with each other;f) taking at least a part of the contents of said bag (5) by means of said syringe (4);g) insulating said first gap (3a) from said second gap (3b) and placing in communication the first gap itself with said third gap (3c);h) conveying the contents taken with said syringe (4) into said containers (6).
- Method according to one or more of the preceding claims, characterized by the fact that said equipment (1) comprises at least first valve means (7) that can be operated to place selectively in communication together said first, second and third gaps (3a, 3b, 3c).
- Method according to claim 3, characterized by the fact that at least the phases b) and d) and/or the phases e) and g) are carried out by intervening on said first valve means (7).
- Method according to one or more of the preceding claims, characterized by the fact that said transit channel (3) comprises at least a further gap (3d) communicating with the outside.
- Method according to claim 5, characterized by the fact that said further gap (3d) is placed between said first and second gaps (3a, 3b).
- Method according to one or more of the preceding claims, characterized by the fact that it comprises, after the phase c), the following phases of :c1) insulating said first gap (3a) from said second and third gaps (3b, 3c) and placing it in communication with said further gap (3d);c2) conveying the air taken by means of said syringe (4) to the outside through said further gap (3d);c3) insulating said further gap (3d) from said first, second and third gaps (3a, 3b, 3c) and repeating the phases c), c1) and c2) until said containers (6) to be filled are completely emptied.
- Method according to claim 7, characterized by the fact that said equipment (1) comprises second valve means (9) that can be operated at least to place in communication said first gap (3a) with said further gap (3d), insulating the first gap itself from said second and third gaps (3b, 3c), and to insulate said further gap (3d) from said first, second and third gaps (3a, 3b, 3c) and by the fact that the phases c1) and c3) are carried out by intervening on said second valve means (9).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000001A ITMO20130001A1 (en) | 2013-01-09 | 2013-01-09 | METHOD FOR FILLING CONTAINERS WITH FRESH AUTOLOGOUS HEMOCOMPONENTS |
| PCT/IB2014/058156 WO2014108852A1 (en) | 2013-01-09 | 2014-01-09 | Method for the filling of containers with autologous fresh blood components |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP2943233A1 EP2943233A1 (en) | 2015-11-18 |
| EP2943233B1 true EP2943233B1 (en) | 2018-06-27 |
Family
ID=47790323
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP14706079.2A Active EP2943233B1 (en) | 2013-01-09 | 2014-01-09 | Method for the filling of containers with autologous fresh blood components |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US9724268B2 (en) |
| EP (1) | EP2943233B1 (en) |
| AU (1) | AU2014206067B2 (en) |
| DK (1) | DK2943233T3 (en) |
| ES (1) | ES2688449T3 (en) |
| IT (1) | ITMO20130001A1 (en) |
| SA (1) | SA515360735B1 (en) |
| WO (1) | WO2014108852A1 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMO20130001A1 (en) | 2013-01-09 | 2014-07-10 | Biomed Device Srl | METHOD FOR FILLING CONTAINERS WITH FRESH AUTOLOGOUS HEMOCOMPONENTS |
| ITMO20140360A1 (en) * | 2014-12-16 | 2016-06-16 | Biomed Device S R L | METHOD FOR FILLING CONTAINERS WITH FRESH BLOOD COMPONENTS |
| DE102015205293A1 (en) | 2015-03-24 | 2016-09-29 | Marc Schrott | Process for the preparation of eye drops |
| DE102016005596A1 (en) * | 2015-10-15 | 2017-04-20 | Kiefel Gmbh | A FILLING DEVICE FOR FILLING A MEDICAL BAG, A METHOD FOR MANUFACTURING SUCH A FILLING DEVICE AND A PLANT FOR PRODUCING MEDICAL BAGS FILLED WITH FLUIDS |
| JP6870239B2 (en) * | 2016-08-24 | 2021-05-12 | 大日本印刷株式会社 | Dispensing equipment and packaging manufacturing method |
| US10781001B2 (en) | 2016-12-01 | 2020-09-22 | Fenwal, Inc. | Fill and finish systems and methods |
| DE202018104658U1 (en) | 2018-08-14 | 2018-11-28 | Vitrum Biologies Inc. | Processing system for liquid biological material |
| US10800556B2 (en) * | 2018-10-25 | 2020-10-13 | Thorne Intellectual Property Holdings, Llc | Methods for preparing autologous blood eye drops |
| US11660255B1 (en) * | 2019-12-23 | 2023-05-30 | Marco Navarro | Liquid medication dispenser |
| DE102020106451A1 (en) | 2020-03-10 | 2021-09-16 | on point medicals GmbH | Device for filling blood products |
| WO2022146763A2 (en) | 2020-12-28 | 2022-07-07 | Baxter International Inc. | Method and system for producing sterile solution filled containers |
| WO2022144746A1 (en) | 2020-12-29 | 2022-07-07 | Nutcracker Therapeutics, Inc. | Filling systems and related container assemblies and methods |
| NL2027499B1 (en) * | 2020-12-29 | 2022-07-21 | Nutcracker Therapeutics Inc | Filling systems and related container assemblies and methods |
| KR102601884B1 (en) * | 2021-11-03 | 2023-11-14 | 김용현 | Serum distribution apparatus and serum distribution kit including the same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT504554B1 (en) * | 2006-12-05 | 2009-10-15 | Beer Franz Dr | SYSTEM FOR THE CRYOKON SURFACING OF BODY FLUIDS AND METHOD FOR THE USE OF SUCH A SYSTEM |
| DE102008004977A1 (en) * | 2008-01-17 | 2009-07-23 | Miltenyi Biotec Gmbh | Device for the removal of biological material |
| WO2011095964A1 (en) * | 2010-02-03 | 2011-08-11 | Fuil Technologies Limited | A method and apparatus for separating a liquid component from a liquid medium |
| ITMO20110058A1 (en) * | 2011-03-16 | 2012-09-17 | Biomed Device S R L | DEVICE FOR THE PREPARATION OF BIOLOGICAL LIQUIDS CONTAINMENT UNIT |
| DE202011004487U1 (en) * | 2011-03-28 | 2012-06-29 | Heinz Meise Gmbh | Device for filling blood products |
| ITMO20130001A1 (en) | 2013-01-09 | 2014-07-10 | Biomed Device Srl | METHOD FOR FILLING CONTAINERS WITH FRESH AUTOLOGOUS HEMOCOMPONENTS |
-
2013
- 2013-01-09 IT IT000001A patent/ITMO20130001A1/en unknown
-
2014
- 2014-01-09 EP EP14706079.2A patent/EP2943233B1/en active Active
- 2014-01-09 AU AU2014206067A patent/AU2014206067B2/en active Active
- 2014-01-09 WO PCT/IB2014/058156 patent/WO2014108852A1/en not_active Ceased
- 2014-01-09 US US14/759,940 patent/US9724268B2/en active Active
- 2014-01-09 DK DK14706079.2T patent/DK2943233T3/en active
- 2014-01-09 ES ES14706079.2T patent/ES2688449T3/en active Active
-
2015
- 2015-07-09 SA SA515360735A patent/SA515360735B1/en unknown
Non-Patent Citations (1)
| Title |
|---|
| None * |
Also Published As
| Publication number | Publication date |
|---|---|
| ITMO20130001A1 (en) | 2014-07-10 |
| SA515360735B1 (en) | 2019-01-28 |
| AU2014206067A1 (en) | 2015-08-13 |
| US20150342828A1 (en) | 2015-12-03 |
| DK2943233T3 (en) | 2018-09-17 |
| ES2688449T3 (en) | 2018-11-02 |
| WO2014108852A1 (en) | 2014-07-17 |
| EP2943233A1 (en) | 2015-11-18 |
| US9724268B2 (en) | 2017-08-08 |
| AU2014206067B2 (en) | 2017-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2943233B1 (en) | Method for the filling of containers with autologous fresh blood components | |
| JP5639149B2 (en) | An integrated means for separating blood components | |
| KR20160146828A (en) | Sterile connector | |
| CN106061513B (en) | Apparatus and method for transferring sterile product between two containers | |
| JP6521351B2 (en) | Virus inactivation and sampling device | |
| US10260037B2 (en) | System and method to divide liposuction fat into aliquots | |
| JP2002500917A (en) | Double package | |
| EP3233149B1 (en) | Method for filling containers with fresh blood components | |
| EP3102668B1 (en) | An apparatus for the sampling and preparation of biomedical samples in a closed sterile environment | |
| US9861736B2 (en) | Methods for extracting platelet-rich plasma for therapeutic injection | |
| EP2525765B1 (en) | Device for the containment of platelet concentrates | |
| IT201800003784U1 (en) | DEVICE FOR THE PREPARATION AND TRANSFER OF BLOOD COMPONENTS | |
| WO2015128860A1 (en) | Vacuum system | |
| HK1228313B (en) | Device and method for transferring a sterile product between two containers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20150731 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| AX | Request for extension of the european patent |
Extension state: BA ME |
|
| DAX | Request for extension of the european patent (deleted) | ||
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
| INTG | Intention to grant announced |
Effective date: 20171208 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BERTONI, MARCO |
|
| GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BERTONI, MARCO |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOMED DEVICE S.R.L. |
|
| GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE PATENT HAS BEEN GRANTED |
|
| AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: BIOMED DEVICE S.R.L. |
|
| REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: BERTONI, MARCO |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 1011737 Country of ref document: AT Kind code of ref document: T Effective date: 20180715 |
|
| REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014027503 Country of ref document: DE |
|
| REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: IPWAY DI FRANCESCO FABIO AND CO., CH |
|
| REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 Effective date: 20180914 |
|
| REG | Reference to a national code |
Ref country code: SE Ref legal event code: TRGR |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180927 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180927 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20180627 |
|
| REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2688449 Country of ref document: ES Kind code of ref document: T3 Effective date: 20181102 |
|
| REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180928 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 1011737 Country of ref document: AT Kind code of ref document: T Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181027 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014027503 Country of ref document: DE |
|
| PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
| 26N | No opposition filed |
Effective date: 20190328 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20181029 Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20190109 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140109 |
|
| PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20180627 |
|
| P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230527 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: MC Payment date: 20241220 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20250127 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20250129 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DK Payment date: 20250127 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20250203 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20250128 Year of fee payment: 12 Ref country code: SE Payment date: 20250127 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20250220 Year of fee payment: 12 Ref country code: BE Payment date: 20250127 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20250127 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20250127 Year of fee payment: 12 Ref country code: IT Payment date: 20250121 Year of fee payment: 12 |
|
| PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20250106 Year of fee payment: 12 |